Lace M. Riggs, PhD - Publications

2012-2016 Department of Psychology California State University, San Bernardino 
 2016-2021 Program in Neuroscience University of Maryland School of Medicine, Baltimore, MD, United States 
 2021- Department of Brain and Cognitive Sciences McGovern Institute for Brain Research at MIT 
Neuroscience, Physiology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Riggs LM, Thompson SM, Gould TD. (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity. Neuropharmacology. 214: 109153. PMID 35661657 DOI: 10.1016/j.neuropharm.2022.109153  0.623
2022 Hasin N, Riggs LM, Shekhtman T, Ashworth J, Lease R, Oshone RT, Humphries EM, Badner JA, Thomson PA, Glahn DC, Craig DW, Edenberg HJ, Gershon ES, McMahon FJ, Nurnberger JI, et al. Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder. Molecular Psychiatry. PMID 35546635 DOI: 10.1038/s41380-022-01609-4  0.518
2022 Highland JN, Morris PJ, Konrath KM, Riggs LM, Hagen NR, Zanos P, Powels CF, Moaddel R, Thomas CJ, Wang AQ, Gould TD. Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (26)- and (5)-Methyl-(26)-hydroxynorketamines. Acs Chemical Neuroscience. 13: 510-523. PMID 35113535 DOI: 10.1021/acschemneuro.1c00761  0.694
2021 Hess EM, Riggs LM, Michaelides M, Gould TD. Mechanisms of Ketamine and its Metabolites as Antidepressants. Biochemical Pharmacology. 114892. PMID 34968492 DOI: 10.1016/j.bcp.2021.114892  0.678
2021 Riggs LM, An X, Pereira EFR, Gould TD. (R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency. Translational Psychiatry. 11: 583. PMID 34772915 DOI: 10.1038/s41398-021-01685-0  0.565
2021 Highland JN, Zanos P, Riggs LM, Georgiou P, Clark SM, Morris PJ, Moaddel R, Thomas CJ, Zarate CA, Pereira EFR, Gould TD. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications. Pharmacological Reviews. 73: 763-791. PMID 33674359 DOI: 10.1124/pharmrev.120.000149  0.66
2021 Riggs LM, Gould TD. Ketamine and the Future of Rapid-Acting Antidepressants. Annual Review of Clinical Psychology. PMID 33561364 DOI: 10.1146/annurev-clinpsy-072120-014126  0.603
2020 Wang AQ, Konrath KM, Highland JN, Riggs LM, Morris PJ, Thomas C, Gould TD, Xu X. P199 - HILIC UPLC-MS/MS methods for the assessment of hydroxynorketamines pharmacokinetics in mouse plasma and brain Drug Metabolism and Pharmacokinetics. 35. DOI: 10.1016/J.Dmpk.2020.04.200  0.677
2019 Riggs LM, Aracava Y, Zanos P, Fischell J, Albuquerque EX, Pereira EFR, Thompson SM, Gould TD. (2R,6R)-hydroxynorketamine acts through a synapse-specific presynaptic mechanism to rapidly potentiate hippocampal glutamatergic transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31216563 DOI: 10.1038/S41386-019-0443-3  0.718
2018 Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA, Gould TD. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews. 70: 621-660. PMID 29945898 DOI: 10.1124/Pr.117.015198  0.648
2017 Iñiguez SD, Flores-Ramirez FJ, Riggs LM, Alipio JB, Garcia-Carachure I, Hernandez MA, Sanchez DO, Lobo MK, Serrano PA, Braren SH, Castillo SA. Vicarious Social Defeat Stress Induces Depression-Related Outcomes in Female Mice. Biological Psychiatry. PMID 28888327 DOI: 10.1016/J.Biopsych.2017.07.014  0.31
2016 Iñiguez SD, Aubry A, Riggs LM, Alipio JB, Zanca RM, Flores-Ramirez FJ, Hernandez MA, Nieto SJ, Musheyev D, Serrano PA. Social defeat stress induces depression-like behavior and alters spine morphology in the hippocampus of adolescent male C57BL/6 mice. Neurobiology of Stress. 5: 54-64. PMID 27981196 DOI: 10.1016/J.Ynstr.2016.07.001  0.343
2014 Iñiguez SD, Alcantara LF, Warren BL, Riggs LM, Parise EM, Vialou V, Wright KN, Dayrit G, Nieto SJ, Wilkinson MB, Lobo MK, Neve RL, Nestler EJ, Bolaños-Guzmán CA. Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 1007-21. PMID 24431458 DOI: 10.1523/Jneurosci.5725-12.2014  0.342
Show low-probability matches.